Mikko Kärppä

1.6k total citations
38 papers, 951 citations indexed

About

Mikko Kärppä is a scholar working on Molecular Biology, Clinical Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mikko Kärppä has authored 38 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Clinical Biochemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mikko Kärppä's work include Mitochondrial Function and Pathology (19 papers), Metabolism and Genetic Disorders (14 papers) and ATP Synthase and ATPases Research (8 papers). Mikko Kärppä is often cited by papers focused on Mitochondrial Function and Pathology (19 papers), Metabolism and Genetic Disorders (14 papers) and ATP Synthase and ATPases Research (8 papers). Mikko Kärppä collaborates with scholars based in Finland, United States and United Kingdom. Mikko Kärppä's co-authors include Kari Majamaa, Ilmo E. Hassinen, Anne M. Remes, Kirsi Majamaa‐Voltti, Seija Uimonen, Martti Sorri, Jukka S. Moilanen, Keijo Peuhkurinen, Harri Rusanen and Pasi Salmela and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

Mikko Kärppä

33 papers receiving 925 citations

Peers

Mikko Kärppä

ECP

CMN

Enrico Bugiardini Italy

Jaime Boero United States

Cécilia Marelli France

Zaid Afawi Israel

Céline Véga France

Virginie Dinet France

Aurélie Méneret France

Rebecca C. Ahrens‐Nicklas United States

Hiroshi Kurisaki Japan

Daniel W. Meechan United States

Enrico Bugiardini Italy

Mikko Kärppä

567 ×0.9

59 ×0.2

34 ×0.2

ECP

54 ×0.4

439 ×3.3

CMN

Citations per year, relative to Mikko Kärppä Mikko Kärppä (= 1×) peers Enrico Bugiardini

Countries citing papers authored by Mikko Kärppä

Since Specialization

Citations

This map shows the geographic impact of Mikko Kärppä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Kärppä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Kärppä more than expected).

Fields of papers citing papers by Mikko Kärppä

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikko Kärppä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Kärppä. The network helps show where Mikko Kärppä may publish in the future.

Co-authorship network of co-authors of Mikko Kärppä

This figure shows the co-authorship network connecting the top 25 collaborators of Mikko Kärppä. A scholar is included among the top collaborators of Mikko Kärppä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikko Kärppä. Mikko Kärppä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winqvist, Satu, Mikko Kärppä, Jukka S. Moilanen, & Kari Majamaa. (2025). Cognitive impairment profile in patients with the m.3243A> G variant in mitochondrial DNA. BMC Neurology. 25(1). 316–316.

Majamaa, Kari, Mikko Kärppä, & Jukka S. Moilanen. (2024). Neurological manifestations in adult patients with the m.3243A>G variant in mitochondrial DNA. BMJ Neurology Open. 6(2). e000825–e000825. 4 indexed citations

Kärppä, Mikko, et al.. (2024). Relative contribution of comorbid diseases to health-related quality of life in patients with Parkinson’s disease. Journal of Patient-Reported Outcomes. 8(1). 84–84.

Sinkkonen, Janne, Valtteri Kaasinen, Eero Pekkonen, et al.. (2023). Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson’s disease. SHILAP Revista de lepidopterología. 2(4). e0000225–e0000225. 4 indexed citations

MaassenVanDenBrink, Antoinette, Gisela M. Terwindt, Joshua M. Cohen, et al.. (2021). Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study. The Journal of Headache and Pain. 22(1). 152–152. 11 indexed citations

Kaasinen, Valtteri, Filip Scheperjans, Mikko Kärppä, et al.. (2021). Validation of the Finnish Version of the Unified Dyskinesia Rating Scale. European Neurology. 84(6). 444–449.

Yardley, Jane, Mikko Kärppä, Yuichi Inoue, et al.. (2021). Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial. Sleep Medicine. 80. 333–342. 53 indexed citations

Yardley, Jane, Mikko Kärppä, Yuichi Inoue, et al.. (2020). Effectiveness and Safety of Lemborexant Over 12 Months in Adults with Insomnia Disorder: Longterm Results From the Phase 3 SUNRISE-2 Study (420). Neurology. 94(15_supplement).

Samuelsson, Kristin, Rayomand Press, Mari Auranen, et al.. (2018). Screening for Fabry disease and Hereditary ATTR amyloidosis in idiopathic small‐fiber and mixed neuropathy. Muscle & Nerve. 59(3). 354–357. 12 indexed citations

10.

Kärppä, Mikko, Hannu Tuominen, Johanna Uusimaa, et al.. (2017). Case report: a novel frameshift mutation in the mitochondrial cytochrome c oxidase II gene causing mitochondrial disorder. BMC Neurology. 17(1). 96–96. 5 indexed citations

11.

Helisalmi, Seppo, Mika Kallio, Marjo Laitinen, et al.. (2017). Molecular Epidemiology of Charcot-Marie-Tooth Disease in Northern Ostrobothnia, Finland: A Population-Based Study. Neuroepidemiology. 49(1-2). 34–39. 21 indexed citations

12.

Palmio, Johanna, Mikko Kärppä, Peter Baumann, et al.. (2016). Novel compound heterozygous mutation in SACS gene leads to a milder autosomal recessive spastic ataxia of Charlevoix‐Saguenay, ARSACS, in a Finnish family. Clinical Case Reports. 4(12). 1151–1156. 13 indexed citations

13.

Lindroos, Markus M., Jussi P. Pärkkä, Markku Taittonen, et al.. (2015). Myocardial glucose uptake in patients with the m.3243A > G mutation in mitochondrial DNA. Journal of Inherited Metabolic Disease. 39(1). 67–74. 11 indexed citations

14.

Rautenstrauß, Bernd, et al.. (2012). A novel mutation of myelin protein zero associated with late-onset predominantly axonal Charcot-Marie-Tooth disease. Journal of Neurology. 259(8). 1585–1589. 5 indexed citations

15.

Hinttala, Reetta, Mikko Kärppä, L. Pajunen, et al.. (2010). POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype. BMC Neurology. 10(1). 29–29. 15 indexed citations

16.

Kärppä, Mikko, et al.. (2009). Amyloid myopathy: a diagnostic challenge. Neurology International. 1(1). 7–7. 12 indexed citations

17.

Remes, Anne M., Reetta Hinttala, Mikko Kärppä, et al.. (2008). Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. Parkinsonism & Related Disorders. 14(8). 652–654. 31 indexed citations

18.

Kärppä, Mikko, Saara Finnilä, Heli Ylä‐Outinen, et al.. (2006). Cytoskeletal structure in cells harboring two mutations: R133C in NOTCH3 and 5650G>A in mitochondrial DNA. Mitochondrion. 7(1-2). 96–100. 6 indexed citations

19.

Kärppä, Mikko, P. Syrjälä, Uolevi Tolonen, & Kari Majamaa. (2003). Peripheral neuropathy in patients with the 3243A>G mutation in mitochondrial DNA. Journal of Neurology. 250(2). 216–221. 36 indexed citations

20.

Majamaa, Kari, Jukka S. Moilanen, Seija Uimonen, et al.. (1998). Epidemiology of A3243G, the Mutation for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes: Prevalence of the Mutation in an Adult Population. The American Journal of Human Genetics. 63(2). 447–454. 291 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact